Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $693.4M | $531.82M | +30.38% |
Operating Income | $-691.08M | $-196.08M | -252.44% |
Net Income | $-705.81M | $-214.12M | -229.64% |
EPS (Basic) | $-6.23 | $-4.20 | -48.33% |
EPS (Diluted) | $-6.23 | $-4.20 | -48.33% |
R&D Expense | $149.32M | $90.34M | +65.29% |
SG&A Expense | $755.35M | $296.76M | +154.53% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $926.12M | $564.05M | +64.19% |
Current Assets | $667.6M | $350.33M | +90.56% |
Total Liabilities | $869.78M | $840.67M | +3.46% |
Current Liabilities | $291.07M | $232.63M | +25.12% |
Stockholders' Equity | $56.34M | $-1.38B | +104.08% |
Cash & Equivalents | $340.95M | $165.77M | +105.68% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-189.04M | $-214.34M | +11.80% |
Investing Cash Flow | $-130.39M | $-40.31M | -223.45% |
Financing Cash Flow | $494.33M | $117.55M | +320.54% |
Dividends Paid | $5.63M | $5.63M | 0.00% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -99.7% | -36.9% | -62.80% |
Net Margin | -101.8% | — | — |
ROE | -1252.8% | — | — |
ROA | -76.2% | — | — |
Current Ratio | $2.294 | — | — |
Debt to Equity | $15.438 | — | — |
Other companies in Life Sciences Tools & Services